跳到主要內容

Yeaman Kevin J 的 Form 4 申報

Dolby Laboratories, Inc.(DLB),2023/10/19 申報

申報編號
0001209191-23-053191
申報時間
2023/10/19
交易日
2023/10/17
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 4 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $74.3 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Yeaman Kevin JCIK 0001200469董事、高階主管(總裁、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/10/17Class A Common StockM行使選擇權取得+9,030$42.98+$388,109.460,909間接
2023/10/17Class A Common StockS賣出處分−1,676$81.53F1−$136,644.2859,233間接
2023/10/17Class A Common StockS賣出處分−7,054$82.49F2−$581,884.4652,179間接
2023/10/17Class A Common StockS賣出處分−300$82.89F3−$24,86751,879間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2023/10/17Class A Common StockM行使選擇權處分−9,030$0.00$063,456間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The shares were sold in multiple transactions at prices ranging from $80.805 to $81.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F2

The shares were sold in multiple transactions at prices ranging from $81.88 to $82.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F3

The shares were sold in multiple transactions at prices ranging from $82.88 to $82.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

備註

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)